Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,331,504
+$4,014,477 QoQ
Shares Held
34,287
+2.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $679,878,666 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,948,745 | $466,781,145 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,664,458 | $50,133,474 | |
| 3 | HLN |
Haleon plc
|
4,639,437 | $46,440,764 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,260,104 | $41,857,126 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
931,364 | $22,287,540 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
34,287 | $20,331,504 | |
| 7 | VTRS |
Viatris Inc
|
881,323 | $11,906,673 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
89,059 | $11,732,631 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,331,504 | 34,287 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,317,027 | 33,488 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,625,868 | 39,660 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,977,808 | 10,363 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,220,496 | 10,447 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,615,904 | 10,248 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $3,854,412 | 10,756 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $3,470,283 | 10,894 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $2,421,019 | 10,539 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $2,212,972 | 10,064 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $2,187,550 | 9,685 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $2,119,420 | 9,601 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $936,600 | 4,182 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $428,258 | 1,540 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $278,894 | 1,332 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $285,595 | 1,212 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $193,045 | 1,076 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $200,522 | 928 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $163,353 | 885 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $840,715 | 4,686 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $705,712 | 4,219 | Shares | Defined | 2021-05-13 | |
| 2020-06-30 | $7,039,417 | 58,177 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,759,707 | 50,192 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||